sftd
Heartware's HVAD Initial Human Implant Marks Clinical Trial
Filed in archive News , Studies , Treatment by Gloria Gamat on March 28, 2006
Heartware's HVAD Initial Human Implant Marks Clinical Trial
A 48 year old male patient suffering NYHA Class IV Heart Failure became the first recipient of HeartWare's HVAD mechanical circulatory assist device on March 22, 2006.

This successful implant is the beginning of HeartWare's CE mark clinical study. The implant was conducted at the Vienna General Hospital and the surgical team was led by Dr Georg Wieselthaler, Clinical Director of Mechanical Circulatory Support at the University of Vienna.

HVAD is the smallest full output long term circulatory assist device under development and HeartWare believes that HVAD is the only device of its type that can be implanted in the space directly surrounding the heart instead of the abdomen -a process that leads to significant potential advantages, especially in terms of ease of surgery and improved recovery (and quality of life) of the patients.

Source: EurekAlert

Permalink: Heartware's HVAD Initial Human Implant Marks Clinical Trial
Tags: heartware  clinical 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/18949
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Heartware's HVAD Initial Human Implant Marks Clinical Trial:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!